BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14961778)

  • 1. Chemotherapy-related nausea and vomiting - past reflections, present practice and future management.
    Miller M; Kearney N
    Eur J Cancer Care (Engl); 2004 Mar; 13(1):71-81. PubMed ID: 14961778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
    Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
    J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of chemotherapy-induced nausea and vomiting.
    Zubairi IH
    Br J Hosp Med (Lond); 2006 Aug; 67(8):410-3. PubMed ID: 16918094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaps exist between patients' experience and clinicians' awareness of symptoms after chemotherapy: CINV and accompanying symptoms.
    Rha SY; Song SK; Lee CE; Park Y; Lee J
    Support Care Cancer; 2016 Nov; 24(11):4559-66. PubMed ID: 27278273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients.
    Shankar A; Roy S; Malik A; Julka PK; Rath GK
    Asian Pac J Cancer Prev; 2015; 16(15):6207-13. PubMed ID: 26434818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing treatment outcomes in patients at risk for chemotherapy-induced nausea and vomiting.
    Thompson N
    Clin J Oncol Nurs; 2012 Jun; 16(3):309-13. PubMed ID: 22641323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy.
    Rusthoven JJ; Osoba D; Butts CA; Yelle L; Findlay H; Grenville A
    Support Care Cancer; 1998 Jul; 6(4):389-95. PubMed ID: 9695208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectively managing chemotherapy-induced nausea and vomiting.
    Middleton J; Lennan E
    Br J Nurs; 2011 Sep 22-Oct 13; 20(17):S7-8, S10-2, S14-15. PubMed ID: 22067540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.
    Osoba D; Zee B; Warr D; Latreille J; Kaizer L; Pater J
    Support Care Cancer; 1997 Jul; 5(4):307-13. PubMed ID: 9257427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
    Egan AP; Taggart JR; Bender CM
    Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).
    Kottschade L; Novotny P; Lyss A; Mazurczak M; Loprinzi C; Barton D
    Support Care Cancer; 2016 Jun; 24(6):2661-7. PubMed ID: 26768436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy.
    Berry WR; House KW; Lee JT; Plagge PB; Meshad MW; Grapski R
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):33-7. PubMed ID: 1485180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
    Molassiotis A; Aapro M; Dicato M; Gascon P; Novoa SA; Isambert N; Burke TA; Gu A; Roila F
    J Pain Symptom Manage; 2014 May; 47(5):839-848.e4. PubMed ID: 24075401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprepitant--where do we stand in the control of chemotherapy-induced nausea and vomiting?
    Sarcev T; Secen N; Zaric B; Milovancev A
    J BUON; 2008; 13(3):333-9. PubMed ID: 18979546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chemotherapy-induced nausea and vomiting on quality of life in indonesian patients with gynecologic cancer.
    Perwitasari DA; Atthobari J; Mustofa M; Dwiprahasto I; Hakimi M; Gelderblom H; Putter H; Nortier JW; Guchelaar HJ; Kaptein AA
    Int J Gynecol Cancer; 2012 Jan; 22(1):139-45. PubMed ID: 22080888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-practitioner perception gap in treatment-induced nausea and vomiting.
    Vidall C; Sharma S; Amlani B
    Br J Nurs; 2016 Sep; 25(16):S4-S11. PubMed ID: 27615540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of concord grape juice on chemotherapy-induced nausea and vomiting: results of a pilot study.
    Ingersoll GL; Wasilewski A; Haller M; Pandya K; Bennett J; He H; Hoffmire C; Berry C
    Oncol Nurs Forum; 2010 Mar; 37(2):213-21. PubMed ID: 20189927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives.
    Schwartzberg LS
    J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nausea, vomiting and quality of life of patients with cancer undergoing antineoplastic treatment: an evaluation by pharmacists.
    de Souza CM; Visacri MB; Ferrari GB; Tuan BT; Costa AP; Barbosa CR; Lima CS; Mazzola PG; Moriel P
    Int J Pharm Pract; 2015 Oct; 23(5):357-60. PubMed ID: 25572714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.